company background image
532815 logo

SMS Pharmaceuticals BSE:532815 Stock Report

Last Price

₹231.95

Market Cap

₹19.6b

7D

-6.2%

1Y

94.8%

Updated

22 Dec, 2024

Data

Company Financials

SMS Pharmaceuticals Limited

BSE:532815 Stock Report

Market Cap: ₹19.6b

532815 Stock Overview

Manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. More details

532815 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends3/6

Rewards

Price-To-Earnings ratio (33x) is below the Pharmaceuticals industry average (33.6x)

Earnings grew by 106.2% over the past year

Risk Analysis

Earnings have declined by 4.9% per year over past 5 years

Has a high level of debt


My Notes

Capture your thoughts, links and company narrative

SMS Pharmaceuticals Limited Competitors

Syncom Formulations (India)

BSE:524470

₹19.2b

Lincoln Pharmaceuticals

BSE:531633

₹16.3b

TTK Healthcare

BSE:507747

₹20.4b

Amrutanjan Health Care

BSE:590006

₹21.7b

Price History & Performance

Summary of share price highs, lows and changes for SMS Pharmaceuticals
Historical stock prices
Current Share Price₹231.95
52 Week High₹398.00
52 Week Low₹118.00
Beta1.36
1 Month Change-3.85%
3 Month Change-38.47%
1 Year Change94.83%
3 Year Change82.35%
5 Year Change473.42%
Change since IPO548.18%

Recent News & Updates

Recent updates

Shareholder Returns

532815IN PharmaceuticalsIN Market
7D-6.2%0.8%-4.3%
1Y94.8%39.7%19.1%

Return vs Industry: 532815 exceeded the Indian Pharmaceuticals industry which returned 39.7% over the past year.

Return vs Market: 532815 exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 532815's price volatile compared to industry and market?
532815 volatility
532815 Average Weekly Movement6.3%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 532815 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 532815's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19871,197Ramesh Potlurismspharma.com

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides.

SMS Pharmaceuticals Limited Fundamentals Summary

How do SMS Pharmaceuticals's earnings and revenue compare to its market cap?
532815 fundamental statistics
Market cap₹19.60b
Earnings (TTM)₹593.38m
Revenue (TTM)₹7.68b

33.0x

P/E Ratio

2.6x

P/S Ratio

Is 532815 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
532815 income statement (TTM)
Revenue₹7.68b
Cost of Revenue₹5.38b
Gross Profit₹2.31b
Other Expenses₹1.71b
Earnings₹593.38m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)7.01
Gross Margin30.02%
Net Profit Margin7.72%
Debt/Equity Ratio50.6%

How did 532815 perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

6%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 09:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SMS Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Anil BurraFirstCall Research